United Kingdom· GB-APID-4831711000001108
Synagis 100mg powder and solvent for solution for injection vials
A medicinal product containing palivizumab, registered in United Kingdom by AbbVie Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Palivizumab
- Manufacturer
- AbbVie Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5013158764750
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Palivizumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumSynagis 100 mgAstraZeneca
- SpainSYNAGIS 100 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEAstrazeneca Ab
- FinlandSynagis2care4 ApS
- NorwaySynagisAstraZeneca
- ItalySYNAGIS*1 flaconcino IM 0,5 ml 100 mg/mlASTRAZENECA AB
- Japanパリビズマブ（遺伝子組換え）アストラゼネカ
- United StatesSynagisSwedish Orphan Biovitrum AB (publ)
- CanadaSYNAGISASTRAZENECA CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Synagis
- Liechtenstein · Synagis
- Norway · Synagis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/70fe68ec-9c24-4a20-85b2-d581a911d3c2 GET /v1/drugs/70fe68ec-9c24-4a20-85b2-d581a911d3c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4831711000001108",
"desc": "Synagis 100mg powder and solvent for solution for injection vials (AbbVie Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "36023911000001103",
"source": "dmd",
"vtm_id": "777050007",
"strength": "100 mg",
"substance": "Palivizumab",
"ingredient": "Palivizumab",
"supplier_code": "20741511000001103"
}See everything about palivizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.